When different healthcare stakeholders have goals that align, patients can stand to benefit. Access this resource today to discover what life sciences organizations can do to help get critical conversations started. This valuable guide will help in developing a roadmap for better, more productive healthcare stakeholder partnerships that can improve patient health and close gaps in care.

Power non-invasive, self-sampling solutions using the Colli-Pee™️  first-void urine collection device. Learn more

Discover how phase-appropriate technology transfers can help you overcome regulatory challenges, reduce costs, and accelerate your path to commercialization. Learn strategies to maximize efficiency and focus on what you do best—innovating new therapies.

Download this report to learn the trends set to define the medtech space, how C-level executives will navigate upcoming QoQs, and the core themes leadership should focus on in 2024 and beyond. 

In this report, learn how recent US legislation, digital transformation, artificial intelligence (AI), the adoption of big data, and much more are redefining what medicine looks like for both patients and providers. Download now.

In a market defined by unpredictability, volatility, and fast-paced evolution, it can be challenging to determine where it’s heading and what executives should concern themselves with in the second half of 2024 and beyond. Interest in obesity drugs has led to billions of new prescriptions. Download to learn more about them.

Finding an effective epilepsy treatment can be arduous. Download this brochure to delve into how IQVIA's expertise and innovative strategic approach can streamline the clinical trial process, helping to get new therapies to patients who need them sooner.

We interviewed dozens of biopharma leaders on the critical success factors for building a Best Practice commercial organization. This report shares what we learned.

Download the white paper to learn how this innovative solution can help optimize your mAb production processes. The findings demonstrate the system's robust capability to sustain strong cell growth and high productivity, facilitating a smooth transition from laboratory to production scale.

This paper explores the costs of setting up a supply chain in Europe for a new biopharma therapy. It outlines key cost drivers & the various levers decision makers can use to affect those costs.